FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online July 1, 2004 as doi:10.1096/fj.03-1161fje.
Published as doi: 10.1096/fj.03-1161fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/12/1401
03-1161fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BANDO, Y.
Right arrow Articles by OGAWA, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BANDO, Y.
Right arrow Articles by OGAWA, S.
(The FASEB Journal. 2004;18:1401-1403.)
© 2004 FASEB

ORP150/HSP12A protects renal tubular epithelium from ischemia-induced cell death

YOSHIO BANDO*,1,2, YOSHITANE TSUKAMOTO{dagger},1, TAICHI KATAYAMA{ddagger}, KENTARO OZAWA§, YASUKO KITAO§, OSAMU HORI§, DAVID M. STERN, ATSUSHI YAMAUCHI|| and SATOSHI OGAWA§

* Department of Anatomy I, Asahikawa Medical College, Asahikawa, Hokkaido, Japan;
{dagger} Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari, Osaka, Japan;
{ddagger} Department of Anatomy and Neuroscience, Osaka University Medical School, Yamada Oka, Japan;
|| Division of Nephrology, Department of Medicine, Osaka Rosai Hospital, Sakai, Japan;
§ Department of Neuroscience, Kanazawa University Medical School, Kanazawa City, Ishikawa, Japan; and
Dean’s Office, Medical College of Georgia, Augusta, Georgia, USA

2Correspondence: Department of Anatomy I, Asahikawa Medical College, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Hokkaido, Japan. E-mail: ybando{at}asahikawa-med.ac.jp

SPECIFIC AIMS

Renal cell injury caused by ischemia/reperfusion (I/R) is often accompanied by acute failure of renal function, which is clinically of importance due to high mortality. 150 kDa oxygen-regulated protein (ORP150) is an inducible endoplasmic reticulum (ER) chaperone with cytoprotective properties in settings of cell stress, such as ischemia/reperfusion (I/R). Based upon the cytoprotective properties of 150 kDa oxygen regulated protein (ORP150) in ischemic condition, we have examined the role of ORP150 in renal ischemia/reperfusion (I/R).

PRINCIPAL FINDINGS

1. ORP150 is expressed in renal epithelial cells in both human and rat kidney after I/R
In acute tubular necrosis accompanying cardiogenic shock, ORP150 was detected mainly in parts of renal tubules in the cortex, and, more frequently, in the medulla. The same pattern of ORP150 expression was found in a case of osmotic nephrosis due to treatment of brain edema.

To further analyze expression of ORP150, rats were subjected to renal I/R by unilateral occlusion of the renal artery. Northern blot showed a marked increase in ORP150 transcripts after I/R on the ipsilateral side, peaking 8–12 h after reperfusion (Fig. 1 A). ORP150 transcripts were also induced on the contralateral side, though to a lesser extent (Fig. 1B ). In situ hybridization of normal kidney revealed a diffuse distribution of ORP150 transcripts in the medulla (Fig. 1C , 1G ). ORP150 transcripts were strongly induced 12 h after I/R in the outer medulla, the area between cortex and medulla (Fig. 1D , 1E , 1H , 1I ). Distribution of ORP150 transcripts overlapped, at least partially, with that observed for Tamm-Horsefall protein (THP) mRNA (Fig. 1F ), a marker of the thick ascending loop (TAL). Immunohistochemical analysis of normal rat kidney displayed low-level expression of ORP150 antigen in the renal medulla (Fig. 1J ), whereas no signal was detected in the cortex (Fig. 1K ). After I/R, ORP150 antigen was markedly induced in renal tubules within the medulla (Fig. 1L ), as well as in portions of renal tubules in the cortex (Fig. 1M) .



View larger version (66K):
[in this window]
[in a new window]
 
Figure 1. Expression ORP150 in rat kidney. Rats were subjected to unilateral occlusion of renal artery for 1 h, followed by reperfusion. A, B) At the indicated time after reperfusion, total RNA was prepared from kidneys of either control animals (sham operation), or the ipsilateral (A) or contralateral side (B) of rats subjected to I/R. Northern blot was performed using cDNA probes for either human ORP150 (upper panels) or human ß-actin cDNA (lower panel), the latter as an internal control. Migration of rRNA is shown on the far left. Densitometric analysis of immunoblots from experiments involved 6 animals in each group/time point is shown to the left of the autoradiogram in A, B. Data are expressed as fold increase compared with sham operated controls (mean±SD; **P<0.01 compared with controls by multiple comparison analysis). C–I) Rat kidney slices were also prepared from control (C, G), ipsilateral (D, E), and contralateral side (H, I) 4 and 12 h after reperfusion, and subjected to in situ hybridization using human ORP150 probe. F) Images obtained with kidney slices from control mice analyzed by in situ hybridization using human Tamm-Horsefall protein (THP). Adjacent sections of control (J, K) and ipsilateral I/R kidney (L, M; 12 h after reperfusion) were subjected to immunohistochemical analysis using ß-human ORP150 antibody. Filled bars in each panel represent 100 µm.

2. ORP150 suppresses cell death in renal epithelial cells
Exposure of MDCK cells, a renal tubular epithelial cell line, to hypoxia caused expression of ORP150 antigen; the latter increased by 12 h and reached a maximum between 24–48 h. Incubation of MDCK cultures in presence of high salt (NaCl, 300 mM) also induced ORP150 antigen. Combination of hypoxia and hyperosmolarity appeared to potentiate ORP150 expression to levels greater than that observed with either stimulus alone. Stable transfectants of MDCK cells were made with antisense or sense constructs of human ORP150. After exposure of these stably transfected cell lines to hypoxia (24 h), antisense transfectants demonstrated detectable, but low levels of ORP150 antigen; vector-alone transfectants showed higher levels of ORP150; and sense transfectants displayed highest levels of ORP150. To evaluate vulnerability of MDCK stable transfectants to hypoxia and hyperosmolar stress, cultures were exposed to hypoxia in presence of NaCl (500 mM) for 36 h, and cell death was evaluated by release of LDH and induction of apoptosis by activation of caspase-3. Results demonstrate increased cell death and activated caspase-3 in antisense transfectants and lowest levels of cell death/activated caspase-3 in sense transfectants. These data indicate a correlation between expression of ORP150 and cellular resistance to hypoxia/hyperosmolar-induced cell death.

3. Furosemide suppressed expression of ORP150 transcripts by unilateral nephrectomy and I/R
The effect of furosemide (a loop diuretic) on ORP150 expression after unilateral nephrectomy and I/R was assessed. Unilateral nephrectomy induced ORP transcripts in the remaining kidney, with peak expression 8–12 h after the procedure. Unilateral I/R also caused prominent up-regulation of ORP150 mRNA, in this case in both kidneys with the most striking effect on the ipsilateral side. Pretreatment with furosemide suppressed expression of ORP150 mRNA in both unilateral nephrectomy and I/R. This suggests the possibility that increased ORP150 mRNA observed in both contralateral/ipsilateral kidneys after I/R may be due to osmotic stress, at least in part.

4. ORP150 suppressed renal dysfunction in a murine model after I/R, by protecting cell viability in TAL
Mice with genetically manipulated expression of ORP150 were used to assess the effect of ORP150 on renal function following I/R injury. For these studies, mice were prepared by right nephrectomy followed seven days later by occlusion of the left renal pedicle for 45 min (I or ischemia) and reperfusion (R). Tg ORP150 mice displayed relative resistance to renal dysfunction, based on the blunted rise in serum creatinine and serum/blood urea nitrogen compared with ORP150+/– animals. Caspase-3 activity was assessed in renal tissue as an index of programmed cell death. Highest levels were observed in ORP150+/– animals, intermediate levels in ORP150+/+ mice, and lowest levels in Tg ORP150 mice.

To further localize the protective effect of ORP150 expression on the kidney, immunohistochemical studies were performed with an antibody selective for activated caspase-3 and renal tubular markers. In the renal cortex, there was no significant difference in the proportion of nuclei staining positively with caspase-3 antibody comparing mice of each genotype (Fig. 2 A). In medulla, caspase-3-positive nuclei were most frequently observed in ORP150+/– mice, whereas they were least abundant in Tg ORP150 animals (Fig. 2A ). Since caspase-3-positive signals identified by this method were likely to include deteriorating cells in casts, we further sought to map distribution of potentially apoptotic cells in portions of the renal segment (Fig. 2B-N ). Although there was no significant difference in the percentage of caspase-3-positive nuclei in proximal and distal renal tubules between the three genotypes, there were differences in TAL based on colocalization with THP (Fig. 2B ). These data suggest that overexpression of ORP150 in the kidney enhances cellular viability in response to ischemic challenge, especially in TAL.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 2. Effect of ORP150 on viability of renal tubular segments. A) 1 wk after unilateral nephrectomy, ORP150+/– (filled bars), ORP150+/+ (shaded bars), or Tg ORP150 (open bars) mice were subjected to I/R (of remaining kidney) or sham procedure (i.e., the latter animals only received nephrectomy). 24 h after I/R, mice were killed and renal sections were incubated with {alpha}-activated caspase-3 antibody, followed by staining with DAPI. Nuclei staining positive for activated caspase-3 were counted in the cortex and medulla, and values were expressed as % positive nuclei (total nuclei were determined by DAPI staining). Mean ± SD is shown (n=6); **P <0.05 vs. observations in ORP150+/+ mice, by multiple comparison analysis. B) Sections were double-stained with segment markers and {alpha}-activated caspase-3 antibody. In each segment, nuclei staining positive with {alpha}-activated caspase-3 antibody were counted and values were expressed as % total nuclei (the latter determined by DAPI staining). The same procedure was also performed in a renal arteriole (Vasc.). Mean ± SD is shown (n=6). C–N) Representative images obtained in ORP150+/– mice are shown. Immunofluorescent images obtained with markers of tubular segments (green; C, G, K) and {alpha}-activated caspase-3 antibody (red; D, H, L) were digitally overlapped (E, I, M). Latter images were further merged with results of nuclear staining using DAPI (light blue; F, J, N). In each panel, open bars represent 100 µm.

CONCLUSIONS AND SIGNIFICANCE

We have identified ORP150 as a stress protein expressed in I/R-mediated injury to the kidney. ORP150 appears to have a cytoprotective effect on renal epithelial cells both in vitro and in vivo in response to I/R and hyperosmolar stress. Though the precise mechanism through which ORP150 exerts its cytoprotective effect in TAL remains to be defined, it is likely to involve its chaperone-like properties in the ER. Since cytoprotective effects of ORP150 (an ER chaperon) were focused on TAL, we suggest that maintenance of ER function is an essential component of a successful stress response in this portion of the nephron in acute renal failure.

Data presented in this manuscript indicate that ORP150 is also induced in response to hyperosmolar stress, and this is accentuated by superimposed oxygen deprivation. Our data suggest that both ischemic and osmolar stress targets a cellular organelle (ER) resulting in an accumulation of immature and unfolded proteins inside (Fig. 3 ). Resistance of MDCK cells to this complex environmental challenge is dependent at least in part on ORP150.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 3. Hypoxia and osmolar stress are directed to a cellular organelle, ER.

FOOTNOTES

To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.03-1161fje; doi: 10.1096/fj.03-1161fje

1 These authors contributed equally to this work.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Inagi, T. Kumagai, H. Nishi, T. Kawakami, T. Miyata, T. Fujita, and M. Nangaku
Preconditioning with Endoplasmic Reticulum Stress Ameliorates Mesangioproliferative Glomerulonephritis
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. D. Arrington and R. G. Schnellmann
Targeting of the molecular chaperone oxygen-regulated protein 150 (ORP150) to mitochondria and its induction by cellular stress
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C641 - C650.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. Kitao, Y. Imai, K. Ozawa, A. Kataoka, T. Ikeda, M. Soda, K. Nakimawa, H. Kiyama, D. M. Stern, O. Hori, et al.
Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation
Hum. Mol. Genet., January 1, 2007; 16(1): 50 - 60.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/12/1401
03-1161fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BANDO, Y.
Right arrow Articles by OGAWA, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BANDO, Y.
Right arrow Articles by OGAWA, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS